|
4 Companies |
|
0 Products |
|
0 Products |
|
2 Mechanisms of Action |
|
1 Trial |
|
6 News |
|
- | Trial completion, Enrollment change: Health Needs of Patients With Kallmann Syndrome (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=249, Completed, Sponsor: Centre Hospitalier Universitaire Vaudois
Active, not recruiting --> Completed | N=148 --> 249
- | Enrollment change: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism (clinicaltrials.gov) - Mar 30, 2017
P2, N=19, Terminated, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed | N=148 --> 249 N=14 --> 19
- Trial completion: Sequential Therapy for Hypogonadotropic Hypogonadism (clinicaltrials.gov) - Feb 9, 2014
P4, N=100, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
N=14 --> 19 Active, not recruiting --> Completed
- Enrollment closed: Health Needs of Patients With Kallmann Syndrome (clinicaltrials.gov) - Jan 30, 2014
P=N/A, N=148, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire Vaudois
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial termination: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism (clinicaltrials.gov) - Apr 16, 2013
P2, N=14, Terminated, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Terminated; Recruitment was at a standstill. We are currently preparing our results for publication.
- Enrollment change: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism (clinicaltrials.gov) - Apr 16, 2013
P2, N=14, Terminated, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
We are currently preparing our results for publication. N=40 --> 14